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Antibody dependent cellular cytotoxicity (ADCC) is a 
recently described mechanism of immunologic lysis in 
which cellular targets sensitized by specific antibodies 
are efficiently and selectively lysed by Fe receptor (FeR) 
bearing nonspecific effectors. Immunoglobulins of var-
ious classes (lgG, lgM, lgA, lgE) and various cellular 
effectors (large granular lymphocytes, monocyte/mac-
rophages, T lymphocytes, neutrophils, and eosinophils) 
can induce ADCC in vitro, and the importance of ADCC 
in vivo is being tested experimentally in resistance to 
viral, bacterial, and parasitic infection, in tumor sur-
veillance, in allograft rejection, and in inflammatory 
diseases. 
There is much indirect evidence that ADCC may be 
the mechanism of damage of different cellular targets 
in skin diseases, but the best direct evidence concerns 
immunologic keratinocyte damage, especially in cuta-
neous lupus erythematosus (LE). We have shown that 
keratinocytes of several species are highly susceptible 
to lymphocyte and monocyte-mediated ADCC, but not to 
neutrophil or eosinophil ADCC in vitro using two dif-
ferent cytotoxicity assays. In contrast, complement was 
a relatively ineffective mediator of lysis of metabolically 
intact keratinocy te targets. 
Patients with certain cutaneous lupus syndromes have 
serum antibodies capable of inducing monocyte and ly m-
phocyte ADCC of targets coated with extractable nu-
clear antigens. We have shown that these antigens ap-
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Abbreviat ions: 
A: a ntibody 
ADCC: antibody-dependent ce ll ula r toxicity 
C: complement 
E: effecto r 
OLE: disco id lupus erythematosus 
FeR: Fe receptor 
FD: fluorescein diacetate 
K: killer 
LE: lupus erythematosus 
LGL: la rge granula r lymphocyte(s) 
nONA: native DNA 
NK: natura l killer 
NLE: neonatal lupus erythematosus 
PBL: periphera l blood leukocyte(s) 
RNP: ribonucleoprotein 
SCLE: subacute cuta neous lupus erythematosus 
SLE: systemic lupus erythematosus 
Sm: Smith antigen 
SSA/Ro: Sjogrens syndrome A a nt igen 
SSDNA: single-stranded DNA 
T: target 
TA: ta rget plus a nt ibody 
TAC: TA plus complement 
TAE: lysis by effectors plus a nt ibody 
T C: lys is by complement 
TE: lys is by effecto rs alone 
TNBS: t rini t robenzene sulfonic acid 
TNP: tr ini trophenol 
UVR: UV radiation 
parently move to the cell membrane of k e ratinocytes in 
vitro following ultraviolet irradiation. In an animal 
model, we have shown that antibodies to SSA/Ro bind 
to human keratinocytes in vivo, especially after ultra-
violet irradiation. This antigen/antibody system is 
highly associated with 3 different photosensitive LE 
syndromes. The experimental linkage of UV radiation 
to autoantibody binding to keratinocytes and the dem-
onstration of mononuclear cell-mediated ADCC causing 
keratinocyte lysis support our h ypothesis that the ker-
atinocyte damage and mononuclear cell infiltrate seen 
histologically in cutaneous LE are part of an ADCC 
process. 
The direct lysis of cellular ta rgets is an important biologic 
end point of many forms of int1ammation, and has been exten -
sively studied in vitro in many types of cytotoxicity assays. 
Cytotoxicity can be the final resul t of antigen -specific humoral 
or cellular immune responses requiring sensitization and elici-
tation phases, or it can be the resul t of so-called "natural" 
immunologic responses requiring no previous ant igenic expo-
sure. Fig 1 is a representation of the many types of cytotoxicity 
described in vitro. In the upper right- hand quadrant a re t he 
components of classical cell-mediated immunity init iated by 
specific T lymphocyte stimulat ion, and in the lower two quad-
rants are antibody-dependent mechanisms of lysis. In the upper 
left-hand quadrant are mechanisms requiring neither specific 
T lymphocytes nor antibody responses. 
Antibody-dependent cellular cytotoxicity (ADCC) is a highly 
efficient means of combining cellular and humoral immune 
mec hanisms of lysis. Various lymphocyte, monocyte/macro-
phage, and granulocyte effectors can induce ADCC in vitro [1-
3]. There is strong direct and indirect evidence t hat ADCC may 
be an important component of host defense against infection 
and malignancy in vivo and may be an important contribution 
to autoimmu ne di seases in human [1-3]. 
In considering diseases in wh ich large nucleated cell s are 
targets of int1ammation, one must consider ADCC, natural 
killing, and classical cell -mediated cytotox icity as potential 
mechanisms of lysis. Complement- mediated lysis may a lso con-
tribute to the lysis of cells whose repa ir mechanisms have been 
impaired by these or by other nonimmunologic mechanisms 
[4]. The importance of lectin-activated cellular cytotox icity in 
vivo is unclear and the importance of antibody- induced pro-
tease release is uncertain except in the tissue damage seen in 
pemphigus vulgaris [5]. Phagocytosis is important in lysis of 
small cellular targets such as bacteria, or of circulating cells 
such as erythrocytes. 
All types of cytotoxicity must be viewed as addit ive compo-
nents of the host response with different kinetics, targets, and 
controls. In classical cell -mediated cytotoxicity, various types 
of foreign antigens are recogni zed in the context of class I and 
II HLA antigens, and cytotoxicity is accomplished by cytotox ic 
T lymphocytes or by "armed" or "activated" macrophages. In 
natural killing, membrane changes in t ransformed cells are 
recognized without prior sensitization [6-8]. The originally 
described "NK (natural killer) cell" was a large granular lym -
phocyte (LGL) [9], which appears to be a lymphocyte with 
some T-cell antigens [10], but monocyte/mac rophages have 
also been shown to induce natural killing of appropriate targets 
l6.5s 
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Immunologic Mechanisms of Cellular Lysis 
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[11]. In ADCC, specificity of cytotoxicity is conferred by lgG 
antibody bathing a ll tissue, and cytotox icity is produced by Fe 
receptor (FeR) bearing effecto rs which recirculate through t is-
sue or are availab le in perivascular locations. HLA differences 
between target and effectors appear to have no significant effect 
on ADCC. There are important differences in the distribut ion 
of agents of specific recogni tio n amo ng t he differe nt types of 
cytotoxicity and the susceptibili ty of different targets to various 
cytotox ic mechanisms is also qui te different. In di seases in 
which ant ibody production is a prominent cha racteristic, and 
in which cellula r infil t rates a re closely associated with specific 
target cell damage , ADCC must be considered as an important 
mechanism of lysis. 
CHARACTERISTICS OF ADCC 
ADCC was originally described as a limited in vitro cytotoxic 
reaction mediated by a type of lymphocyte ca lled the killer (K) 
cell [12) . S ince removal of monocytes, T lymphocytes, or B 
lymphocytes did not eliminate ADCC effector function, it was 
assumed t hat t he K cell was a nonadheren t, non-T, non-B 
lymphocyte [13]. As better techniques of effector ce ll separation 
became avail ab le, and as more in vitro and in vivo target 
systems were used , it became clear t hat seve ra l different lym-
phocytes could perform as K cells [14,15), and that monocytes 
[1 6], mac rophages [17], neutrophils [18], and eosinophils [19) 
were all potent ADCC effectors under appropriate conditions 
in vitro. It a lso was found that the K and NK cell s might 
represent ove rl appi ng populations of cells with t he morphology 
of LGL. The recent identification of monoclonal antibodies to 
K and NK cell populations [15], and the use ofthe fluorescence-
activated cell sorter to efficient ly separate cell populations for 
study has furt her refin ed our understanding of K cell popula-
tions. The use of single-cell ADCC and natural killing assays 
have a lso made the precise ident ification of ADCC effector 
populatio ns possible. K cell activi ty can be defined in 4 lym-
phocyte populations [20): large granular lymphocytes; small 
non-T lymphocytes; T-helper lymphocytes; and T cytotox ic/ 
suppresso r lymphocytes. Both K and NK activity is present in 
t he LGL population [9), and indeed LGL's are t he most effi-
cient K cell effectors [20]. LGL represent 5-15% of peripheral 
blood lymphocytes (PBL) and are found in the spleen, and less 
densely in lymph nodes surrounding the antibody-producing 
germinal centers [21). Wahlin and Perlmann [20) have shown 
that small non-T lymphocytes, and T-helper and T -cytotoxic/ 
suppressor cells can also mediate ADCC. Although T cells make 
up the largest K cell subset, t hey are less effi cient on a cell per 
cell basis than are LGL. They also showed that the T -helper 
phenotype could be induced in vitro by incubation of K cells 
with antibody-sensitized targets. Sophisticated monoclonal an-
tibody studies have shown considerable antigenic overlap be-
tween LGL and T cells [4,5], and there is still debate as to 
whether K and NK activity in the LGL fraction is in overlap-
ping cell fractions, or in clearly distinct populations 
[9]. In short, t he K cell (defined as t he lymphocyte ADCC 
effecto r) population may contain LGL, small non-T lympho-
cytes, and both T-helper and T-suppressor-cytotoxic lympho-
cytes. The exact relationship of the different K cells is not 
known, but it has been speculated that they may all represent 
different stages in T lymphocyte development . 
The abili ty of monocyte, lymphocyte, and granulocyte effec-
tors to lyse different types of targets is also variable. Against 
nucleated targets, lymphocytes and monocytes are the most 
effective ADCC effectors [3). Neutrophils are effective against 
erythrocytes, ova, parasites, and bacteria [3). Since monocytes, 
LGL, T-helper lymphocytes or T -suppressor lymphocytes, and 
non-T, small lymphocytes are all capable of mediating ADCC 
of nucleated parenchymal cell targets, t he identification of any 
of these ce lls by morphology, by histochemical staining, or by 
monoclonal antibodies in t issue infiltrates ra ises the possibility 
of the ADCC as a mechanism of tissue damage. 
The antibody classes and subclasses which induce ADCC are 
also broader t han origina lly described. In some experimental 
conditions lgG3 seems to be the most effective subclass of 
ADCC inducing antibody, but IgGh IgG2 , and lgG. are also 
effective [22). There seems to be some variation in effectiveness 
of antibody subclasses between species. IgM, lgA, and lgE can 
also induce ADCC, but lgM activity may require trace amounts 
of IgG [23]. lgA and lgE appear to be very effective using 
neutrophil and eosinophi l effectors against ova and parasites 
in vitro [19). 
Many different types of targets have been shown to be 
sensitive to ADCC lysis in vitro; erythrocytes, normal and 
transformed cell lines, fresh parenchymal cells, nucleated cells 
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in short term cul t ure, PBL, bacte ri al, ova, parasites, and virus 
in fected ce lls [1]. 
Targets sensitized by specific a nt ibody a re lysed by ADCC 
in a two-step process, as illustrated in Fig 2. Binding of FeR-
positive effectors to t he sensit ized ta rgets requires divalent 
cations a nd metabolic energy. When a sufficient density of 
a nt ibody- receptor complexes is formed, a burst of metabolic 
activity is induced, a nd the effecto rs release toxic products 
which cause ta rget cell lysis. In t he case of K cell-mediated 
ADCC, discrete t ra nsmembra ne pores are produced in targets 
(24], a nd subsequent destruction occurs by colloid osmotic lys is. 
ADCC-induced da mage requires close contact of effecto r a nd 
ta rget; "innocent bysta nder" lysis of ta rgets not sensitized by 
a nt ibody occurs to a lim ited degree, a nd only with erythrocyte 
targets (1]. Thus ADCC is a precise cytotox ic process able to 
induce isolated cellular da mage. ADCC by T lymphocytes ap-
pears to be lymphotoxin dependent (25], while that mediated 
by neutrophils or mac rophages is dependent on hydrolyt ic 
enzymes (26] or toxic oxygen products [27]. It is not yet clear 
whether t hese cytotox ic chemicals produce transmembrane 
pores such as those seen in K ce ll -mediated ADCC. ADCC can 
be inhibited by immune complexes or free antibody, probably 
by FeR blockade. Cort icoste roids inhibit ADCC by altering 
effecto r popu lations, by inte rfering wit h specific antibody pro-
duction, or by inhibi t ing a ntibody-FeR interaction. Gamma 
interferon is a potent in vit ro stimula nt of monocyte and K cell 
ADCC, and bac illus Ca lmette-G uerin (BCG) strongly stimu-
lates monocyte ADCC [3]. 
Even t hough it may be difficul t to demonstrate t he impor-
tance of a complex in vitro immunologic process in vivo, t here 
is strong evidence t hat ADCC is important in host defenses 
aga inst in fection and ma ligna ncy a nd a lso may be a n important 
mediator of autoimmune phenomena in vivo. ADCC is an 
efficient means of killing herpes virus- infected autologous or 
a lloge neic ce lls in vitro [28] and t he kinetics of a ntibody re-
sponses to herpes infection imply that ADCC may be an im-
portant early in vivo mechanism of limi t ing herpes infection . 
Neut rophils, eosinophils, and specifi c IgA a re excellent means 
of disabli ng ova and pa rasites in vit ro, a nd occur concurren t ly 
in t he gastrointestina l t ract in response to infestation in vivo. 
Antibody Dependent 
Cellular Cytotoxicity 
Antibody 
Antibody Binding 
-®~ '~~.•tor Step I : ~ Effo<to' Attoohmo"' 
Fe Receptor 
Step II : 
Target Lysis 
FIG 2. This sc hematic representation of ADCC shows the two dis-
tinct steps involved in lysis of antibody-coated targets. 
TABLE I. Diseases in which ADCC may be a mechanism 
Disease 
Lupus erythematosus 
Herpes virus infection 
Erythema mul t iforme 
Graft-versus- host disease 
Malignant melanoma 
Viti ligo 
Alopecia areata 
Vasculitis 
Scleroderma 
Mycosis fungoides 
Target 
Keratinocytes, Langerhans cells, 
inflammatory cells 
Keratinocytes, ? endothelial cells 
Keratinocytes, endothelial cells 
Keratinocytes, Langerhans cells, 
fibroblasts 
Transformed melanocytes 
Melanocytes 
Hair follicles 
Endothelial cells 
Fibroblasts, mast cells 
Langerhans cells, lymphocytes 
In animal models of growth of human melanoma, monocyte/ 
macrophage ADCC appears to be an important in vivo t umor-
cidal mechanism (29]. Autoimmune hemolytic anemia a nd neu-
tropenia in Felty's syndrome both appear to be examples of 
ADCC of circulating hematologic targets as they pass through 
the spleen [1]. The evidence that ADCC in vivo may produce 
tissue damage seen in various autoimmune diseases is just now 
being accumulated. 
CUTANEOUS DISEASES AND ADCC 
For ADCC to be considered as a potential mechanism of 
t issue da mage in any disease, t he following criteria must be 
met: t he disease must show histologic evidence of cytotox icity 
of a discrete cellular population; an infil t rate of inflammatory 
cells (preferab ly lymphohistiocytic) must be in close apposition 
to the target; and specific antibody to the target in question 
must be demonstrated by local deposition or systemic produc-
tion. Table I lists diseases involving the skin which fu lfill these 
cri te ria . Of course, ADCC may be one of multiple additive 
cytotoxic processes involved in tissue damage in t hese diseases. 
There is growing evidence of t he importance of antibody in 
diseases such as graft-versus-host disease, a lopecia a reata, vi-
tiligo, and erythema mult iforme, which were previously t hought 
to be completely mediated by ce ll -mediated immune responses. 
The remainder of t his review will focus on the disease in which 
t here is best evidence that ADCC is a mechanism of cutaneous 
da mage , t he disease best cha racterized by autoant ibody pro-
duction , lupus erythematosus. 
ADCC AND CUTANEOUS LUPUS ERYTHEMATOSUS 
Lupus erythematosus (LE) is a mult iorgan disease with many 
clinical presentat ions including several distinct cutaneous pres-
entations: acute systemic lupus erythematosus (SLE), chron ic 
discoid lupus erythematosus (DLE), subacute cutaneous lupus 
erythematosus (SCLE) , and neonatal lupus erythematosus 
(NLE) . The single unifying feature of human a nd animal LE 
is t he production of autoantibodies, especially t hose specific fo r 
nuclear antigens [30]. Specific ant inuclear ant ibodies a re be-
lieved to participate in t he immune complex-generated glomer-
ul onephri t is and vasculitis seen in SLE, but the precise mech -
anism of tissue damage in cutaneous LE has unt il recent ly been 
only indirectly studied. 
Recent study ofthe neonatal lupus syndrome has reawakened 
t he interest in possible a nt ibody- mediated mechanisms of cu-
taneous LE. In NLE, photosensitive papulosquamous skin dis-
ease presents during t he first six months of life, sometimes in 
associat ion wit h idiopat hic congeni tal heart block (31]. The 
occurrence of t he skin disease coincides with t he presence of 
maternally-derived t ransplacental anti-SSA/ Ro lgG ant ibody 
in the neonates, and disappears when t he maternal antibody 
t iters in t he neonate diminish. This same antibody system is 
highly associated with t he photosensitive cuta neous LE syn-
dromes SCLE [32], described by Sontheimer and colleagues, 
and "ANA-negative LE", described by Maddison, Provost and 
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Proposed Mechanism for Cutaneous Lupus 
A. UVL 
B. 
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Antibody to nuclear antigens 
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cell membrane 
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of AOCC effectors 
FiG 3. This proposed mechan ism for the pathogenesis of cutaneous 
lupus erythematosus shows how basal keratinocytes located above the 
dermal -epidermal junction (hatched bar) are induced by UVR to be· 
come ta rgets of ADCC effected by specifi c antibody and lymphocytes 
or monocytes. 
Reich lin [33]. These a nti-SSA-associated photosens it ive lupus 
syndromes have prov ided t he impetus fo r expe riments to link 
UV radiat ion (UVR) a nd a ntibodies to sequeste red nuclear 
a n t igens to the keratinocyte damage wh ich is a ha llma rk of 
cutaneous lupus sy ndromes. 
W e propose t hat UVR-induced immunologic k erati nocyte 
da mage in cuta neous LE is produced by ADCC of basal kera-
t inocytes as out lined in Fig 3. UVR pe netrating to the leve l o f 
the basal kerat inocyte induces nuclear a n t igen expression on 
cell membra nes in t he epidermis. Antibody to t hese sequestered 
a n t ige ns is present in LE se rum a nd bathes t he tissue, where 
it binds to a ntigen appea rin g on t he surface of basal kera t ino-
cytes . F eR -bearing ADCC e ffecto rs b ind to these sens it ized 
kerat inocytes at the basa l zone, a nd so me a re stimulated to 
p roduce me mbra ne da mage of kerat inocytes. R ecurrent UVR 
exposure, ke ratinocyte lysis , and AD CC effector accumu lat io n 
a nd immigrat io n produce a chro nic infl am mato ry infiltrate and 
persistent basal ke rat inocyte da mage. To date we have shown 
that UVR modulates nuclear a nt igen expression on keratino-
cytes in vit ro [34], t hat simil a r modulation of sp ecifi c an tibody 
bi ndin g to human keratinocytes can be produced in vivo in a n 
a nim a l model,* tha t ta rgets coated with nuclear a n t igens ca n 
be lysed by approp riate lupus se rum plus ADCC effecto rs [35], 
a nd t hat human kerat inocytes a re efli c ien t ly lysed by ADCC 
effectors [36]. The remainder of this rev iew will presen t t he 
data a nd techniques supporti ng t his hypothesis. 
* Lee LA , Stevens .J, Krueger G, Emam M, Weston WL, Norris DA: 
An an imal model of antibody binding in cutaneous lupus. Submi tted 
for publicat ion. 
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MATERIALS AND METHODS 
Ultraviolet Radiation /ndu.ction of Binding of Antibodies to Nu.clear 
A ntigen..s on the Su.rface of H u.man Keratinocytes 
Human keratinocytes were isolated from neonatal foresk ins in pri· 
mary cul tu re in low calcium (0.1 mM) , serum-free defi ned medium by 
the method of Boyce and Ham [37], producing nonstratified disc rete 
monolayer colon ies. First passage cultu res were maintained in glass 
chamber slides (Lab Tek , Miles Lab, Naperville, Illinois) for irradiation 
and subsequent immunofluorescence evaluation. Staining with anti· 
keratins and monoclonal antibodies for human Langerhans cells 
(0KT6, Ortho Pharmaceuticals) confirmed t hat 100% of t he cells in 
culture were keratinocytes. 
Cultures were irradiated with 0, 0.2, or 2.0 mJ/cm2 UVR emitted 
from a Hanovia Luxor hot quartz lamp, and at 8 and 24 h the cells 
were examined fo r binding of antinuclear antibodies, for viability, and 
for cell permeability. Binding of monospecific human LE patient sera 
wit h ant i-native DNA (ant i-nONA) , ant i-single-stranded DNA (anti · 
SSDNA) , anti-SSA/ Ro (ant i-Sjogrens Syndrome A antigen), anti-RNP 
(ant i-ribonucleoprotein) or anti-Sm (anti-Smith antigen) specificity, 
and binding of a monoclonal mouse antihistone antibody was examin ed 
in cells, both before and after acetone fixation by techniques previously 
desc ribed in detail [34]. Binding of antibody to keratinocytes was 
analyzed by an improved two-step immuno!luorescence technique pre· 
viously described [34]. 
Routine cell viabili ty measured in irradiated cultures was measured 
by ethidium bromide wit h acridi ne orange, by propidium iodide exclu · 
sion, and by !1uorescein diacetate uptake [34]. Double-labeling tech-
niques with fluorescein or rhodamine tluorochromes was used to si-
multaneously assess binding of antinuclear antibodies and viability. In 
these experiments, viability was measured using !1uorescein diacetate 
uptake, or by exclusion of antihistone monoclonal antibodies by meth· 
ods described in detail elsewhere [34]. The effect of inhibi t ion of protein 
synthesis on antinuclear antibody binding and viabili ty was studied 
after preincubation wit h graded doses of cycloheximide (Sigma, St. 
Louis, Missouri.} 
Antibody Binding to Human Shin In Viuo 
In order to assess binding of human anti·SSA/Ro antibody to human 
kerat inocytes in vivo without the background produced by tissue fluid 
human IgG, we engrafted nude mice (BALB/c nu+/ nu+) with normal 
human skin, waited one month, and then injected the animals i.v. with 
either normal human serum , or with anti-SSA/ Ro antiserum from 
patients with SCLE. Identification of human IgG from injected anti-
serum in biopsies from human skin graft and from mouse skin were 
examined using standard indirect immunofluorescence techniques de· 
veloped by Dr. Clark Huff. 
So me animals were engrafted with multiple grafts and the effect of 
increasing doties of UVR from Sylvania FS40 lamps was dete rmined by 
visual quantitation of lgG deposit ion . Visual evaluation of coded sam-
ples assu red objectivity of observation. 
ADCC of Nu.clear Protein Antigen Coated Targets 
A comparison of the abi li ty of monospecific anti-SSA, ant i-RNP, 
and anti -Sm antisera to induce ADCC of nuclear antigen-coated ta rgets 
was performed using nuclear antigen-coated erythrocytes, monocyte 
and lymphocyte effectors, and monospecific antisera from LE and 
mixed connective t issue disease patients [35]. Targets were coated by 
standard techniques with rabbit thymus extract containing RNP and 
Sm antigen, or with Wil -2 extract containing SSA antigen plus other 
antigens. Antigen coating was ver ified by passive hemaggluti nation, 
and antisera were heat- inactivated and absorbed with noncoated eryth· 
rocyte targets to assure t hat any lysis seen was not complement 
dependent or due to alloreactivity. Monocyte and lymphocyte effectors 
were separated from heparinized venous blood by Percoll cont inuous 
density gradients using standard techniques [35]. ADCC was deter· 
mined by measurement of "'Cr release from chromium-labeled targets 
in t he presence of antibody and effectors in 3-h tube ADCC assays. All 
appropriate controls for maximum lysis, spontaneous lysis, antibody-
mediated lysis, complement-mediated lys is, and effector-mediated lys is 
were performed. Percent-specific lysis (ADCC,.,,,,;vc ""m"' - ADCC,.,,.,ive 
~nnnl was determ ined for ant i-RNP, anti-Sm, and ant i-SSA and com-
pared to posit ive control ADCC systems using antiherpes antibody and 
herpes antigen-coated targets, and antitetanus toxoid antibody and 
tetanus toxoid-coated targets. 
ADCC of Kerat inocyte Targets 
Different cytotoxic mechanisms of keratinocyte cytotoxicity were 
compared using chromium release assays and dye up take assays of cells 
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in suspension and in monolayer [36]. ADCC, natural killing, antibody-
mediated lysis a nd a nt ibody-complement- mediated lys is were studied 
using 4 different trinitrophenol (TNP)-coated keratinocyte targets: 
fresh huma n foresk in keratinocytes grown in serum-free defined me-
dium , HEp -2 cells (a huma n epit helial ca rcinoma cell line), PAM-212 
cells (transformed mouse epidermal cells generously provided by Dr. 
Stua rt Yuspa) and RSC (transformed rabbit ep ithelial cells provided 
by Dr. Louis P izer). Keratinocytes were grown in T 75 t issue cultu re · 
flasks (Falcon, Becton Dickinson, Oxnard, Ca lifornia ), and were chro-
mium labeled by overnight incubation with 100 J.LCi of sodium chromate 
(Na Cr5 10 3 , New England Nuclear, Boston, Massachusetts). After 
washing, cells were put in suspension by rapid t rypsin ization (3- 10 s 
with 0.3 % t rypsin , Sigma), were again washed, and were TNP-coated 
by 15 min incubat ion with 0.05 nM t rin t robenzene sulfonic ac id (T NBS, 
Sigma). Uniform TNP coating was verified by indirect immunofluores-
cence using anti -TNP rabbi t ant isera, and chrom ium labeling was 
verified by spot counting with a Beckman gamma counter. The ant i-
body used for cytotoxicity assays was heat-inactivated anti-TNP rabbit 
antiserum prepared by immunization with TNP-coated huma n eryth-
rocytes followed by absorbtion with uncoated erythrocytes. Monocyte, 
lymphocyte, and neut rophi l effector populat ions were prepared by 
standa rd Percoll techniques. The monocyte effecto r population con-
tained 80-85% esterase positive OKM3+ (Ortho Pharmaceuticals) 
nonactivated monocytes. The lymphocyte population conta ined 85-
TABLE II. Cell membrane expression of nuclear antigens 
Speci ficity of Baseline After UV 
antisera sta iningn irradiation 
Anti-SS-A/Ro ± 3+ 
Anti-RNP ± 3+ 
Anti-Sm ± 3+ 
Anti-nDNA 0 0 
Anti-SSDNA 0 0 
Anti histone 0 0 
Normal human serum 0 0 
a Fluoresce nce graded 0- 4+. 
95% T lymphocytes and 10-15% NK/K cells as determined by Leu 11 
staining (Becton Dickinson). The neut rophi l preparations were 80% 
neut rophils by morphology of stat-stain preparations. 
Cytotox icity was determined by 3 h chromium release assays in 
microtiter plates (Falcon, Becton Dickinson). Combinations of target 
(T) , effectors (E), antibody (A) , and complement (C) were combined 
and compared to Triton X maximal lysis by t he following formula: 
o/c L . cpm experimental - cpm spontaneous 
0 
YSIS = cpm maximal - cpm spontaneous 
Lysis by antibody (TA), by a ntibody plus complemen t (TAC), by 
complement alone (TC) , by effectors alone (TE), and by effectors plus 
ant ibody (TAE) were all determined. ADCC was defined as TAE-TE. 
Cytotoxicity of human keratinocytes was a lso measured in a flu ores-
cein diacetate (FD) uptake assay. First passage human kerati nocytes 
were grown in serum -free defined medium for 5-7 days in Lab Tek 
slide chambers and were TNP-coated by 15 min incubation with 0.5 
mM TNBS. After washing, different combinations of target, ant ibody, 
effectors, and complement were added to the chambers and were 
incubated for 3 h in a 37· c humidified incubato r. The chambers were 
then washed and 100 J.Lg/ml of FD in 2% acetone was added for 15 min 
at 37· c. FD uptake was visually counted on a fluorescence microscope 
(Olympus) after samples had been coded for objectivity. 
In an attempt to reverse t he resistance of human keratinocytes to 
complement-dependent lysis, human keratinocytes were preincubated 
with 0.25, 2.5, and 25 J.L/ ml cycloheximide (Sigma) for 16 h before 
chromium release cytotoxicity assays. 
RESULTS 
Ultraviolet Radiation Induction of Binding of Antibodies to 
Nuclear Antigens on the S urface of Human Keratinocytes 
Irra diation of keratinocyte cu ltures with low doses (0.2- 2 .0 
mJ/cm 2 ) of UVR produced selective changes in t he binding of 
a ntibodies to nuclear antigens o n t he surface of huma n kera ti-
nocytes. Ant ibodies to t he extractable, soluble antigens SS-A, 
F IG 4. A, In t his cul tu re of huma n keratinocytes (X 400), t he red nuclei stained with propidium iodide are evident but no green fluorescence 
indicating binding of hum an lgG from monospecific--antitluclea r ant ibody-containing serum was seen on the cells over the red nuclei. B, UV 
ir radiated kerati nocyte cultures show fluorescent green granula r deposi ts indicating anti-SSA on t he ce ll membrane over a cent ral red propidium 
iodide-stained nucleus. The white arrow s hows t he distinct border of this keratinocyte with discrete granular staining (X 630). Similar stain ing 
was also see n with ant i-RNP and ant i-Sm a nt ibodies afte r UV irradiation. 
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RNP, and Sm produced bright (3+ ), granular staining afte r 
irradiation in a subpopulation of ce ll s, compared to baseline 
(Table II ). In contrast, no cell membrane sta ining was seen 
with antibodies to SSDNA, nD NA, or histones . If t he cells were 
fixed and permeabilized befo re incubation with monospecific 
ant inuclear ant isera, the nuclear and cytoplas mic sta ining pat-
terns were exactly what one would expect from t he specific . 
ant isera in quest ion [34 ]. 
Fig 4A shows keratinocyte cul tures prior to irradiation after 
incubatio n with anti-SS-A antiserum and a fluorescinated sec-
ond antibody, then fixation, a nd nuclear counterstaining with 
propidium iodide. Only red nuclea r stai ning was seen by fluo-
rescence microscopy. Figure 4B shows a keratinocyte cult ure 8 
h after UVR irradiation and similar staining. In addition to the 
red nuclea r propidium iodide sta ining, tine granular green anti-
SS-A deposit ions were seen on the surface of the cell stopping 
at the cell margin (a rrow). Fixation of t he cell before incubation 
with anti-SS-A produced dense, diffuse cytoplasmic and 
speckled nuclear staining whether the cells were irradiated or 
not. An t i-RNP and anti-Sm produced similar results. 
A critica l question is whether the appare nt migration of 
extractable nuclear anti gens to the cell membranes of irradiated 
keratinocytes is simply due to membrane damage, cell death, 
and passive leakage. Use of a variety of viability assays showed 
that irradiation produced 3 distinct populations of cells, and 
t hat cell membrane nuclear ant ige n exp ression occurred in 
injured but not dead keratinocytes. 
Fig 5 shows the ce ll populations in irradiated keratinocyte 
FIG 5. Th is UV -irradiated keratinocyte cul ture was examined using 
an FD viabili ty technique which stained viable cells bright green (B) 
and with a monoclonal antihistone technique in which dead cells 
permeable to the mouse monoclonal antihistone showed red nuclear 
and perinuclear staining (A) after counterstaining with a rhodaminated 
goat antimouse lgG second antibody. In addition, a third population 
was seen (C) which was not permeable to the antihistone, but which 
still showed inte rmediate, globular FD uptake. This third population 
was the one which stained with anti-SSA, anti-Sm, or anti-RNP as 
indicated in other experiments. 
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cultures simultaneously examined by FD uptake and ant i-
histone antibody exclusion assays. The population of cells with 
bright red nuclear and perinuclear staining indicating anti-
histone uptake through damaged ce ll membranes is indicated 
by the letter A (dead cells). In addition, an intact viable 
population of green fluorescent cells able to hydrolyze and 
retain FD (B, live cells) was uniform ly found. A third popula-
tion (C, injured) had low levels of FD uptake, but was not 
permeable to antihistone antibodies. This populat ion had light 
green globular staining and could be distinguished uniformly 
from the dead populat ion of cells which did not take up or 
hydrolyze FD. Under t he conditions employed, 10-20% of the 
cells were injured, 45-55% were dead, and 25-35% of the cells 
were alive and actively hydrolyzing FD. In other double- labeling 
experiments, it was shown that t his injured population was the 
population of cells which expressed nuclear ant igens in the cell 
membrane [34]. 
A further indication this effect was not merely due to cell 
death was that cycloheximide produced dose-dependent 
suppression of the effect, indicating t hat act ive protein synthe-
sis was critical for the movement of nuclear antigens to the cell 
membrane. 
Antibody Binding to Human Skin In Vivo 
Because of the fragility of keratinocytes following UVR in 
culture, and the demonstration of selective cell membrane 
nuclear exp ression in only a minority of ce lls, we developed a 
nude mouse model to study the binding of t he anti-SS-A to 
human kerat inocytes in tissue from which background human 
IgG had been removed by engraftment on a nude mouse.* The 
nude mouse also offers the advantage that t he SSA ant igen is 
detectable in human skin graft but not detectable in adj acent 
mouse skin by indirect immunofluorescent techniques. 
Fig 6A shows a biopsy from human skin in the nude mouse 
which had been injected one day previously i.v. wi th normal 
human serum. One can identify the epidermis (E) wit h keratin-
ocyte nuclei stained with propidium iodide, the dermis (D) , and 
the dermal-epidermal junction (arrow). Human IgG was not 
seen in the biopsy in the dermis or epidermis. The only f1uo-
rescence seen was in t he stratum corneum in an interrupted 
pattern, and may have been nonspecific. 
A biopsy from a human skin graft from a nude mouse injected 
i.v. with human anti-SS-A is shown in Fig 6B. Bright f1uores-
cence indicating deposition of human IgG in the human skin is 
seen uni fo rmly and densely along the basal keratinocytes, often 
outlining the cells. Patchy bright staining within the epidermis 
and over inflammatory cells in the dermis is also evident . 
Although t he dermal-epidermal junction is still largely dark, 
large grains were often seen at the basal pole of basal kerati-
nocytes. Adjacent mouse skin showed no deposition of IgG 
anti-SSA. 
A group of animals were grafted with multiple biopsies of 
human skin and each graft was exposed to increasing doses of 
UVR before injection of anti-SS-A antiserum and subsequent 
biopsy. In each instance, there was a dose-dependent increase 
in binding of human IgG from the SS-A specific antisera in 
irradiated skin. Although UV was not necessary for the binding 
of anti-SS-A to the surface of keratinocytes in a xenograft to a 
nude mouse, it augmented the binding in vivo just as it did in 
vitro in irradiated keratinocyte cultures. 
ADCC of Nuclear Protein Antigen-Coated Targets 
Whether sera from LE patients contain antibodies capable 
of inducing ADCC of nuclear antigen-coated targets is an 
importan t corollary to the finding that ant ibodies to nuclear 
antigens can bind keratinocytes in vitro and in vivo. Erythro-
cyte targets were coated wit h the same antigens (SSA, RNP, 
Sm) ident ified on the surface of keratinocytes following UVR 
in vitro, and these coated targets were then tested in ADCC 
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FIG 6. Established human skin grafted onto nude mice was examined by immunoflu orescent techniques fo r human IgG deposition in vivo 
afte r t he mice we re injected with normal serum or with serum conta ining anti-SSA. A, In t his sample from a mouse injected with normal human 
serum , the epidermis (£) is separated from t he dermis (D) by the dark dermal-epidermal junction zone indicated by a white arrow. Epiderma l 
nuclei were coun te rsta ined wit h red propidium iodide. A sma ll amount of bright staining in t he stratum corneum is seen. B, In th is specimen 
from a mouse injected with anti-SSA, deposits of human IgG a re seen as discrete white fl ecks densely a round and over t he basal keratinocytes 
(BK), within the epidermis, a nd in isolated cells wit hin the dermis. The dermal-epidermal junction (arrow) is still la rgely negative for lgG 
although dense globules of staining were seen directly under basal keratinocytes. Propidium iodide staining of t he epidermal nuclei is far less 
intense t han t he fluorescent staining fo r lgG in this photo. Epidermis (£), dermis (D). 
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FIG 7. Monocyte-mediated ADCC of 
erythrocytes coated with nuclear anti-
gens and sensit ized with monospecific 
ant i-RNP, anti -Sm, or ant i-SSA is com-
pared to ADCC of erythrocytes coated 
with either tetanus toxoid antigen or 
herpes simplex virus ant igen, a nd sensi-
tized with appropriate ant ibodies. Mean 
+SEMis indicated for a ll sera. Numbers 
in parentheses indicate t he number of 
experiments performed and p values a re 
indicated for t he ADCC produced by 
each antiserum against its appropriate 
ta rget. (From Norris et al {35] ). 
assays during the sera of LE patients and source of ADCC-
inducing antibodies. 
A in comparison to 2 other ant igen/antibody systems (tetanus 
toxoid and herpes simplex) . Significant ADCC was seen with 
all 3 groups of LE patients' sera. The lysis with ant i-SS-A was 
part icularly significant and equivalent to t hat seen wit h the 
Fig 7 shows monocyte ADCC of targets coated wit h nuclear 
antigens and sensiti zed with ant i-RNP, ant i-Sm, and anti-SS-
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best positive con trol, i.e., tetanus toxoid-coated erythrocytes 
sensitized wit h a nti-tetanus toxoid [35]. 
ADCC of Kera.tinocyte Targets 
ADCC of TNP-coated keratinocyte targets a nd erythrocyte 
targets were compared usi ng a sho rt-term 3-h chromium release 
assay as shown in Fig 8. Percent specific lysi s (ADCC,.,cc;r.c 
.,,;"""""- ADCCconnol '"'"'") for 3 d ifferent effector populations is 
shown with significa n t lys is being indicated by p values over 
eac h bar. Cu lt ured human keratinocytes, HEP-2 cell cultures, 
and PAM -212 cell cul t ures were significant targets of monocyte 
and lymphocyte, but not neut rophil , ADCC. Alt hough rabbit 
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keratinocytes were not lysed at t he standard ant ibody dilution 
of 1:100, increasing t he an t ibody to 1:10 dilution a lso produced 
sign ificant monocyte and lymphocyte ADCC of t hese targets. 
TNP-coated erythrocytes were lysed by a ll effectors, and mon-
ocyte ADCC of erythrocyte targets was consistently greater 
t han t hat caused by lymp hocytes. As in previous studies, nu-
cleated targets were more suscept ible to lymphocyte t han to 
monocyte ADCC. In t hese experiments, spontaneous lysis, an-
t ibody mediated lysis, and antibody complement -mediated lysis 
were all insignificant (data not shown). Complement mediated 
lysis of t he human keratinocyte or HEP-2 targets was not 
s ign ificantly augmented by increasing specific an t ibody or com-
p lement sou rce, but was significant ly increased by 16-h incu-
bation with cyclohexam ide. For all keratinocyte targets, direct 
cellular cytotoxicity (natural killing) by both monocyte and 
lymphocyte effectors was elevated, espec ially with human ker-
atinocyte targets. To determine if this natural killing was due 
to t he membrane changes induced during trypsin ization to 
bring these targets into suspension, we developed the FD via-
bility tec hnique using human keratinocytes to study lysis of 
keratinocytes in monolayer co lonies . 
The endpoint used to evaluate cytotoxicity in t he FD assay 
is shown in Fig 9. Figure 9A shows a 95 % viable cul ture of 
TNP-coated kerati nocytes stained with FD afte r a 3-h incu-
bation wit h 1000:1 rat io (effector:target) of purified monocytes. 
The few dead cells (D) appear as dark areas. Fig 9B shows a 
s imilar colony of TNP-coated keratinocytes after incubation 
with anti-T NP sera and a 1000:1 ratio of monocyte effecto rs, a 
combination chosen to produce maximal monocyte ADCC. 
Only 22 % of t he 400 coun ted cells showed bright FD uptake 
with the remainder appearing as dark nuclei surrounded by 
very ligh t cytop lasm ic ring (arrows). Fig 10 shows t he end point 
of ADCC using t he FD assay, expressed as percent viable cells 
ADCC in Fluorescein Diacetate Cytotoxicity Assay 
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viable TNP-coated keratinocytes surviving 3 h cul ture alone (T) with 
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TABLE III. Immunologic lysis of keratinocy te targets 
ADCC 
Monocyte 
Lymphocyte 
Neutrop hil 
Natural hilling 
Monocyte 
Lymphocyte 
Neutroph il 
Antibody mediated 
lysis 
A ntibody-com.plement 
mediated lysis 
Human kerat.inocytes Human erythrocytes 
75 ± 2.1 % (p < .0001) 58± 2 (p < .001) 
73 ± 3.8% (p < .0001) 30 ± 2 (p < .01) 
1 ± 1.0% 56± 3 (p < .001) 
9 ± 1.3% 
1 ± 0.2% 
1 ± 0.4 % 
0.3 ± 0.1 
2 ± 0.3 
1 ± 0.1 
1.1 ± 0.1 
1.2 ± 0.1 
2 ± 0.3 
75 ± 3.2 (.p < .001) 
with different ratios of monocyte and lymphocyte effectors 
compared to spontaneous cytotoxicity (T) and antibody-me-
diated cytotoxicity (TA). Progressive ADCC with both mono-
cyte and lymphocyte effectors was seen, reducing viable kera-
tinocytes to 25% and 27%, respectively. In contrast to the 
results seen using trypsinized targets in chromium release 
assays, no natu ra l killing with either effector population was 
seen. Antibody a lone or antibody plus complement did not 
produce s ignificant lysis. 
A summary of cytotoxicity results using chrom ium release 
and FD assays is shown in Table III. Nonnucleated erythrocyte 
targets were susceptible to complement lysis and to ADCC by 
monocytes and neutrophils and to a lesser degree by lymphocyte 
effectors. Human keratinocytes were significantly ki lled by 
both monocyte and lymp hocyte effectors in ADCC assays; while 
monocytes and lymphocytes were equivalent ADCC effectors 
of keratinocyte lysis in monolayer cul tures, lymphocytes were 
superior effectors in suspension chromium release assays. Sim-
ilar susceptibili ty to monocyte and lymphocyte ADCC was seen 
with t ransformed keratinocyte cu ltures from humans, mouse 
and rabbit . Complement lysis of keratinocytes was insignificant 
unless t he cells were preincubated with cycloheximide. Natural 
killing of keratinocyte cul tures by both monocytes and lymp ho-
cytes was seen when cell membranes were a ltered by trypsini-
zation, but was not seen in healthy monolayer cult ures. 
DISCUSSION 
The experimental resul ts presented in t he previous section 
prov ide 4 pieces of evidence supporting our hypothesis that 
ADCC is an important mechanism of inducing t he keratinocyte 
damage which characterizes cutaneous LE: autoantibodies from 
LE patients' sera specific for t he soluble nuclear antigens SS-
A, RNP, and Sm attached to human keratinocytes in culture, 
following UV irradiation; anti-SS-A binds to keratinocytes in 
a human skin graft on a nude mouse, especially after UV 
irradiation of t he graft; ADCC-inducing antibodies specific for 
SS-A, RNP, and Sm are fou nd in LE patients' sera; and ADCC 
by monocyte and lymphocyte effectors is a better way of lysing 
viable keratinocyte targets t han is antibody-complement me-
diated lysis. The strong association of antibodies to SS-A wit h 
3 different clinical cutaneous lupus syndromes [31,33], and the 
apparent antibody dependence of cutaneous LE in neonatal LE 
[31] can be used as strong support for our hypothesis that 
antibodies to certain nuclear ant igens can bind to keratinocytes 
and induce effector mechanisms of keratinocyte lysis, especially 
ADCC. At t his point, t he strongest association with photosen-
sitive cutaneous LE is seen with autoant ibodies to SS-A but 
anti-RNP and anti-SS-E may also prove to be importa~t in 
the keratinocyte ADCC in LE. An important point to recognize 
about t hese results is t hat t hey are the first evidence that 
autoantibodies in LEmay be directly involved in t he pathogen-
esis of t issue damage of cutaneous disease and are not simply 
involved as serum markers of "subsets" of t he lupus disease 
spectrum. 
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Prev ious investigators have shown that IgG and complement 
membrane attack complex components can be found on the 
membranes of basal keratinocytes in DLE and in SLE [38], 
and have proposed t hat complement-mediated keratinocyte 
damage is the mechanism of cutan eous LE. Our in vitro com-
parison of different mechani sms of keratinocyte lysis strongly 
suppo rts the idea that ADCC is a far more effective means of 
lys ing antibody sensitized keratinocytes than is complement. 
However, keratinocytes whose repair mechanisms a re impaired 
by UVR or by ADCC damage, may be more susceptible to 
complement-induced change, as were our keratinocyte cultures 
pretreated with cyclohex imide. Indeed other investigators h ave 
shown that simi lar pretreatment with cyclohexamide inhibits 
complex lipid synthesis necessary to repair ·complement in-
duced membrane damage [39]. There are other pieces of ev i-
dence, however, against t h e s ign ifi cant involvement of comple-
ment activation in t he pathogenesis of cutaneous LE. The lack 
of a neutrophilic infil t rate in cutaneous LE, which is seen in 
other clearly complement-dependent diseases, and t he presence 
of photosens itive cutaneous sk in disease in complement com-
ponent deficient patients, make it less like ly that complement 
activation is a major component of photosensitive cutaneous 
LE. There -is a lso no strong direct ev idence for cell-mediated 
cytotox icity and natural killing as mechanisms o f keratinocyte 
damage in cutaneous LE. 
Of the diseases presented in Table I, cutaneous LE is the 
most like ly to be large ly antibody-dependent, and ADCC ap-
pea rs to be t he major antibody-dependent mechanism of kera-
t inocyte cytotox icity. Investigation into t he many other possi-
ble cutaneous examples of ADCC has only just begun. There is 
strong evidence t hat ADCC is one of several importan t mech-
an isms of host control of malignant melanoma; is one of several 
cytotox ic mechan isms in eryth ema multiforme; and may be a 
mechanism of some o f t he cytotox ic damage seen in GVH, 
viti ligo, a lopecia a rea ta, and vasculitis. 
ADCC must be considered as a potential mechanism of t issue 
damage in any disease in which monocytes, LGL, T lympho -
cytes, small non-T lymphocytes, or even granu locytes a re as-
sociated with destruction of a discrete target population and in 
which autoa nt ibody is locally or system ically produced. One 
must remember, however, t hat ADCC is on ly one of several 
ce llular mechanisms of cytotox icity by these same effecto rs, 
and is on ly one of several antibody-mediated mechanisms of 
cell lys is. Cytotoxicity as an end point of inflammation is a 
complex in te rplay between diffe rent mechanisms, which in a ny 
di sease may occur s imultaneously. Understanding the relative 
importance of different mechanisms in specific diseases and 
devising treatment strategies to suppress these mechanisms is 
a major ch a llenge for t he investigator in immunodermatology. 
REFERENCES 
1. Fuson EW, Hubbard RA, Suganthary DG, Andrews RB, Beard 
MR, Whittaker RL: Antibody dependent cell mediated cytotox-
icity: effectors, signals and mechanisms. Surv lmmunol Res 
2:327- 340, 1983 
2. Perlmann P, Perlmann H, Wigzell H: Lymphocyte- mediated cy-
totox icity in vitro. Induction and inhibition by humoral antibody 
and nature of effector cells. Transplant Rev 13:91-114, 1977 
3. Norris DA, Fritz KA: Antibody dependent cellular cytotoxicity and 
skin disease, Progress in Diseases of t he Skin . Edited by R 
Fleischmajer. New York, Grune & Stratton, 1984, pp 89-110 
4. Biesecker G: Membrane attack complex of complement as patho-
logic mediator. Lab Invest 49:237-249, 1983 
5. Farb DM , Dykes R, Lazarus GS: Anti-epidermal ce ll surface pem-
phigus antibody detaches viable epidermal cells from culture 
plates by activation of proteinases. Proc Nat! Acad Sci USA 
75:459- 463, 1978 
6. Herberman RB , Nunn ME, Lavrin DH: Natural cytotoxic reactiv-
ity of mouse lymphoid cells against syngeneic and allogeneic 
tumors. I. Distribut ion of reactivity and specificity. lnt J Cancer 
16:216- 222, 1975 
7. Kiessling R, Klein E, Wigzell H: Natu ral killer ce lls in the mouse. 
I. Cytotoxic cells with specificity for mouse Moloney leukemia 
cells. Specificity and distribution according to genotype. Eur J 
lmmunol 5:112- l22, 1975 
Vol. 85, No. 1 Supplement 
8. Herberman RB: Natural killer (N K) cells and their possible roles 
in resistance against disease. C!in lmmunol Rev 1:1-65, 1981 
9. Timonen T , Ortaldo JR, Herberman RB: Characteristics of human 
large granular lymphocytes in relationship to natural killer and 
K cells. J Exp Med 153:569-581, 1981 
10. Fast LD, Hauser JA, Newman W: Evidence forT cell nature and 
heterogeneity with natural killer (NK) and antibody dependent 
cellular cytotoxicity (ADCC) effectors: a comparison with cyto-
toxic T lymphocytes. J Immunol 127:448-45 1, 1981 
11. Tagliabue A, Mantovani A, Ki lgallen M, Herberman RB, McCoy 
JL: Natural cytotoxicity of mouse monocytes and macrophages. 
J lmmunol 122:2363-2370, 1979 
12. Perlmann P, Perlmann H: Contactual lysis of antibody coated 
chicken erythrocytes by purified lymphocytes. Cell Immunol 
1:300-315, 1970 
13. Brier AM , Chess L, Schlossman S: Human antibody dependent 
cellular cytotoxicity: isolation and identification of a subpopu-
lat ion of peripheral blood lymphocytes which kill antibody coated 
autologous targets. J Clin Invest 56:1580- 1585, 1976 
14. Sciae JG, Rieber EP, Hadam M, Reithmiller G: Lymphocytes with 
T cell markers cooperate with lgG antibodies in the lysis of 
human tumor cells. Nature 265:158-160, 1977 
15. Abo T , Balch CM: A differentiation antigen of human NK and K 
cells identified by a monoclonal antibody (HNK-1). J lmmunol 
127:1020-1029, 1983 
16. Norris DA, Morris RM, Sanderson RG , Kohler PL: Isolation of 
functional subsets of human peripheral blood monocytes. J lm-
munol1 23:166-172, 1979 
17. Nathan C, Bruckner L, Kaplan G, eta!: Role of activated macro-
phages in antibody-dependent lys is of tumor cells. J Exp Med 
152:183-196, 1980 
18. Shaw GW, Levy PC, Lobuglio AF: Human lymphocyte, monocyte 
and neutrophil ant ibody-dependent cellular cytotoxicity towards 
human erythrocytes. Celllmmunol 41:122-133, 1978 
19. Moser G, Sher A: Studies of the antibody-dependent killing of 
schistosomula of Schistosoma monsoni employing haptenic tar-
get antigen. J lmmunol 126:1025-1034, 1981 
20. Wahlin B, Perlmann P: Cha racterization of human K cells by 
surface antigens and morphology at the single cell level. J Im-
munol 131:2340-2347, 1983 
21. Ritchie A WS, J ones K, Micklein HS: The distribution and possible 
significance of cells ident ified in human lymphoid t issue by the 
monoclonal antibody HNK-1. Clin Exp Immunol 51:440- 447, 
1983 
22. Ralph R: Immunoglobulin class of antibody effective in macrophage 
ADCC, Macrophage Mediated Antibody Dependent Cellular Cy-
totoxicity. Edited by HS Koren. New York, Marcel Dekker, 
1983, pp 71- 84 
23 . Perl mann H, Perlmann P, Moretta L, Riinnholm M: Regulation of 
lgG antibody dependent cellular cytotoxicity in vitro by lgM 
antibodies. Scand J lmmunol 14:47-60, 1981 
24. Simone CD, Henkart P: Permeability changes induced in erythro-
cyte ghost targets by antibody dependent cytotoxic effector cells: 
evidence for membrane pores. J Jmmunol124:954-963, 1980 
25. Kondo LL: Lymphotoxin as a mechanism of lymphocyte antibody-
dependent cellular cytotoxicity. J Immunol126:1131-1133, 1981 
26. Clark RA, Klebanoff SA: Studies on t he mechanism of antibody-
dependent polymorphonuclear leukocyte mediated cytotoxicity. 
J Jmmunol 119:1414-1418, 1977 
27. Borregard N, Kragballe K: Role of oxygen in antibody-dependent 
cellular cytoxicity mediated by monocytes and neutrophils. J 
Clin Invest 66:676-683, 1980 
28. Kohl S, Moore CM: Human antibody-dependent cellular cytotox-
icity and natural killer cytotoxicity to herpes simplex virus 
infected autologous and allogeneic cells. Immunology 48:187-
193, 1983 
29. Steplewski Z, Lubeck MD, Koprowski H: Human macrophages 
armed with murine immunoglobulin G2a antibodies to tumors 
destroy human cancer cells. Science 221:865- 867, 1983 
30. Steinberg AD, Raveches ES, Laskin CA, Smith HR, Santoro T , 
Miller ML, P lotz PH: Systemic lupus erythematosus: insights 
from animal models. Ann Intern Med 100:714-732, 1984 
31. Lee LA: Neonatal lupus, Current Issues in Dermatology, vol 2. 
Edited by JP Callen, JE Rasmussen. Boston, GK Hall, 1984, pp 
71- 86 
32. Sontheimer RD, Maddison PJ, Reichlin M, Jordon RE, Stasyny 
P, Gi lliam JN: Serologic and HLA associations in subacute 
cutaneous lupus erythematosus: a clinical subset of lupus ery-
thematosus. Ann Intern Med 97:664-671 , 1982 
33. Maddison PJ, Provost TT, Reichlin M: Serologic findings in pa· 
tients with "ANA negative" systemic lupus erythematosus. Med-
icine (Baltimore) 60:87-94, 1981 
34. LeFeber WP, Norris DA, Ryan SR, Huff JC, Lee LA, Kubo M, 
Boyce ST, Kotzin BL, Weston WL: Ultraviolet light induced 
binding of antobodies to selected nuclear antigens on cultured 
human keratinocytes. J Clin Invest 74:1545-1551, 1984 
35. Norris DA, Ryan SR, Fritz KA, Tan EM, Deng JS, Weston WL: 
The role of RNP, Sm and SS-A/Ro specific antisera from pa-
July 1985 ANTIBODY-DEPENDENT CELLULAR CYTOTO XICITY AND SKIN DISEASE 175s 
t ients with lupus e rythematosus in inducing a nt ibody-dependent 
cellular cytotox icity (ADCC) or ta rgets coated with nonhistone 
nuclear antige ns. Cli n Immunol Immunopathol 31:311- 320, 1984 
36. Norris DA , Kiss inger RM, Fri tz KA, Rya n SR, Weston WL: 
Systematic comparison of antibody mediated mecha nisms of 
keratinocyte lys is in vit ro. J Immunol, in press. 
37. Boyce ST, Ha m RG : Calcium regulated differentiation of normal 
human epiderma l keratinocytes in chemically defined clona l 
culture a nd serum -free serial cu lture. J Invest Dermatol 
81 (suppl):33s- 40s, 1983 
38. Biesecker G, Lavin L, Zis kind M, Koffler D: Cutaneous localization 
of t he membrane attack complex in discoid and systemic lupus 
erythematosus. N E ng! J Med 306:265- 270, 1982 
39. Schlager S I, Ohanian SH, Borsos T : Correlation between the ability 
of tumor cells to resist humoral immune attack a nd thei r abi lity 
to synthesize lipid. J Immunol 120:463- 471, 1978 
